16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.
Eligibility criteria
Qualifiers
Informed Consent signed by the patient (all sex and gender)
Patients' age from ≥ 18 to no age limit at time of study inclusion
American Society of Anaesthesiologists (ASA) physical status classification I to IV
Patients with resectable non-small cell lung cancer (NSCLC) deemed operable by minimally invasive surgical technique.
Disqualifiers
Previous thoracic surgery on the same side within 3 months
Lung cancer complicated with pleural empyema
Patients with chronic pain who receive opioids/gabapentin/pregabalin
Patients who consume opiates/benzodiazepines
Trial design
Treatments tested in this trial
- 16 F chest tube
- 24 F chest tube
- Early removal
- Standard removal
Treatment groups
124 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov